Who invested in 89Bio?
89Bio's investors include OrbiMed, RA Capital Management, Longitude Capital, OrbiMed Israel and Longitude Capital/ RA, and 2 more on record.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$348Mraised across 2 rounds since 2018, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From 89Bio's own website: 3 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
89Bio's investors include OrbiMed, RA Capital Management, Longitude Capital, OrbiMed Israel and Longitude Capital/ RA, and 2 more on record.
89Bio has raised $348M across 2 rounds since 2018.
89Bio's most recent round was an Undisclosed round of $288M in Jan 2025.
Its most recent round, $288M in Jan 2025, is also its largest on record.
89Bio's first round on record, in Oct 2018, was backed by OrbiMed Israel, Longitude Capital/ RA and OrbiMed US and 1 others.
89Bio's latest named round is an Undisclosed round, in Jan 2025.
89Bio is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.